Humanized beta-thalassemia mouse model containing the common IVSI-110 splicing mutation

Area of Science:

• Genetics
• Hematology
• Molecular Biology

Background:

• Splicing mutations in the beta-globin gene are a primary cause of beta-thalassemia.
• The severity of beta-thalassemia, ranging from mild (intermedia) to transfusion-dependent, correlates with the degree of normal beta-globin synthesis reduction.
• Developing effective therapies necessitates accurate preclinical models.

Purpose of the Study:

• To generate and characterize a humanized mouse model for beta-thalassemia.
• To specifically model the common IVSI-110 splicing mutation.
• To provide a platform for testing novel therapeutic strategies.

Main Methods:

• Generation of a humanized mouse model using a bacterial artificial chromosome (BAC) containing the human beta-globin locus.
• Introduction of the IVSI-110 splicing mutation into the human beta-globin locus in mice.
• Comparison of beta-globin chain synthesis between mice with the mutation and control mice.

Main Results:

• The humanized IVSI-110 mouse model exhibited a 90% reduction in human beta-globin chain synthesis compared to controls.
• This significant decrease was attributed to aberrant splicing caused by the IVSI-110 mutation.
• The model accurately reflects the splicing defect observed in human beta-thalassemia patients.

Conclusions:

• The developed humanized mouse model effectively recapitulates the molecular pathology of beta-thalassemia caused by the IVSI-110 mutation.
• This model serves as a valuable preclinical tool for evaluating therapies aimed at restoring normal splicing.
• Further research using this model can accelerate the development of treatments for beta-thalassemia.